INTERSOUTH PARTNERS VII L P 13D/13G Filings for Lyra Therapeutics, Inc. (LYRA)

INTERSOUTH PARTNERS VII L P 13D and 13G filings for Lyra Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-13
4:23 pm
Unchanged		2022-12-3113GLyra Therapeutics, Inc.
LYRA		INTERSOUTH PARTNERS VII L P738,203
2.300%		0
(Unchanged)		Filing
2021-02-12
4:16 pm
Purchase		2020-12-3113GLyra Therapeutics, Inc.
LYRA		INTERSOUTH PARTNERS VII L P738,203
5.700%		738,203increase
(New Position)		Filing